GIM
MEDP icon

Glenmede Investment Management’s Medpace MEDP Stock Holding History

Glenmede Investment Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.44M Sell
4,748
-38,333
-89% -$16.7M 0.01% 531
2025
Q2 		$13.5M Buy
+43,081
New +$12.9M 0.07% 273

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Glenmede Investment Management's MEDP Position: Q3 2025 in Review

Glenmede Investment Management reduced its Medpace (MEDP) stake by 89% in Q3 2025, selling an estimated $16.7M and leaving 4,748 shares worth $2.44M. The position accounts for 0.01% of the portfolio, ranked #531.

Glenmede Investment Management first reported a position in MEDP in Q2 2025 and has held it in 2 quarters since. The position peaked at $13.5M in Q2 2025. 672 funds tracked by Wall St. Rank hold MEDP as of Q3 2025.

  • Glenmede Investment Management held 4,748 shares of Medpace worth $2.44M as of Q3 2025.
  • Glenmede Investment Management sold 38,333 Medpace shares in Q3 2025, an estimated $16.7M.
  • Medpace made up 0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #531 holding.
  • Glenmede Investment Management first reported a position in Medpace in Q2 2025 and has held it in 2 quarters since.
  • Glenmede Investment Management's Medpace position peaked at $13.5M in Q2 2025.
  • 672 funds tracked by Wall St. Rank held Medpace as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.